Update on the List of Reimbursable Medications in France
On December 3, 2025, the Caisse Nationale d'Assurance Maladie (Cnam) released the latest version of the list of medications covered by the basic healthcare regime, known as VEI. This publication defines the reimbursable products and serves as a reference for doctors, pharmacists, and social security beneficiaries.
Classification of Medications
The list is organized according to the therapeutic importance of the medications, which are divided into three categories:
- Vital (V): Essential treatments that are fully covered.
- Essential (E): Common products that are reimbursed at a high rate.
- Intermediate (I): Medications that are partially reimbursed.
This classification not only determines the reimbursement rate but also guides medical prescriptions and pharmacy dispensing, ensuring controlled access to medications for patients.
Information Provided for Each Category
For each category, the official table provides several pieces of information, including:
- The official code of the medication (CODE_PCT)
- The commercial name
- The active substance (DCI)
- The category
- The public price
- The reference rate used for reimbursement
Examples of products in the Essential category include ACARBOSE ADWYA 100 mg for diabetes and ACETAZOLAMIDE 250 mg, illustrating the attention given to chronic treatments.
Coverage of Various Pathologies
The list covers a wide range of diseases, including:
- Hypertension
- Diabetes
- Respiratory diseases
- Allergies
- Mental health disorders
- Other chronic diseases
Each update incorporates price changes, additions or removals of molecules, and allows for the alignment of reimbursement with the reality of the pharmaceutical market.
Strategic Importance for Pharmacies and Beneficiaries
Beyond its medical aspect, this list also plays a strategic role for pharmacies and beneficiaries. In the current context of payment delays from the Cnam to pharmacies, knowing which medications are reimbursed is crucial for anticipating the financial impact.
Access to the List
The Cnam regularly updates the list, which can be consulted on its website or through specialized portals. Click here to access the list.
Also Read:
Pharmacies: 200 Billion Dinars in Unpaid Debts at the Heart of the Crisis
